Keywords: Genzyme, Sanofi, Fabrazyme, Framingham plant, FDA, EMA

Genzyme Framingham plant now cleared by US and EU regulators

Article | 24 January 2012

French drug major Sanofi (Euronext: SAN) said yesterday that the US Food and Drug Administration has approved its subsidiary Genzyme& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in